Sanara MedTech Inc. (SMTI)
- Previous Close
32.21 - Open
32.82 - Bid --
- Ask 33.12 x 100
- Day's Range
32.00 - 32.82 - 52 Week Range
26.06 - 46.40 - Volume
7,650 - Avg. Volume
13,398 - Market Cap (intraday)
278.948M - Beta (5Y Monthly) 1.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.52 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
44.00
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
sanaramedtech.comRecent News: SMTI
Performance Overview: SMTI
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SMTI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SMTI
Valuation Measures
Market Cap
278.95M
Enterprise Value
285.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.12
Price/Book (mrq)
6.22
Enterprise Value/Revenue
4.39
Enterprise Value/EBITDA
-987.89
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.62%
Return on Assets (ttm)
-7.10%
Return on Equity (ttm)
-10.29%
Revenue (ttm)
64.99M
Net Income Avi to Common (ttm)
-4.3M
Diluted EPS (ttm)
-0.52
Balance Sheet and Cash Flow
Total Cash (mrq)
5.15M
Total Debt/Equity (mrq)
26.45%
Levered Free Cash Flow (ttm)
-97.56k